ICICIPRULI - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 3.6
| Stock Code | ICICIPRULI | Market Cap | 93,054 Cr. | Current Price | 643 ₹ | High / Low | 707 ₹ |
| Stock P/E | 67.5 | Book Value | 93.0 ₹ | Dividend Yield | 0.13 % | ROCE | 8.86 % |
| ROE | 7.42 % | Face Value | 10.0 ₹ | DMA 50 | 646 ₹ | DMA 200 | 630 ₹ |
| Chg in FII Hold | -1.67 % | Chg in DII Hold | 1.76 % | PAT Qtr | 390 Cr. | PAT Prev Qtr | 299 Cr. |
| RSI | 45.7 | MACD | -4.28 | Volume | 3,20,189 | Avg Vol 1Wk | 10,64,020 |
| Low price | 517 ₹ | High price | 707 ₹ | PEG Ratio | 4.04 | Debt to equity | 0.19 |
| 52w Index | 66.6 % | Qtr Profit Var | 19.8 % | EPS | 9.53 ₹ | Industry PE | 80.8 |
💹 Core Financials: ICICI Prudential Life Insurance (ICICIPRULI) shows modest profitability with ROE at 7.42% and ROCE at 8.86%, reflecting limited efficiency compared to peers. Debt-to-equity ratio of 0.19 indicates low leverage, ensuring financial stability. Quarterly PAT improved from ₹299 Cr. to ₹390 Cr., showing healthy growth of 19.8%. Dividend yield of 0.13% is negligible, offering minimal income. EPS at ₹9.53 remains modest relative to market capitalization.
📊 Valuation Indicators: Current P/E of 67.5 is lower than the industry average of 80.8, suggesting relative undervaluation within the sector, though still expensive in absolute terms. Book value of ₹93 against CMP of ₹643 implies a P/B ratio of ~6.9, which is high. PEG ratio of 4.04 indicates stretched valuation relative to growth prospects. Intrinsic value appears lower than CMP, pointing to limited upside at current levels.
🏢 Business Model & Competitive Advantage: ICICIPRULI operates in life insurance, with strong positioning in retail protection, savings, and annuity products. Its competitive advantage lies in brand equity, distribution reach, and bancassurance partnerships with ICICI Bank. However, profitability remains under pressure due to high operating costs, competitive pricing, and regulatory constraints.
💰 Entry Zone Recommendation: Considering DMA 50 at ₹646 and DMA 200 at ₹630, the stock is trading near averages, showing consolidation. A favorable entry zone would be ₹600–₹620 during corrections. Current levels remain slightly overvalued relative to intrinsic metrics.
📈 Long-Term Holding Guidance: ICICIPRULI remains a stable insurance player with growth potential in protection and annuity segments. Long-term investors can hold cautiously, while new investors should wait for dips to improve risk-reward balance.
Positive
- Quarterly PAT growth of 19.8% shows earnings momentum.
- Low debt-to-equity ratio (0.19) ensures financial stability.
- Strong brand equity and bancassurance partnerships.
- P/E ratio (67.5) is lower than industry average (80.8).
Limitation
- ROE (7.42%) and ROCE (8.86%) reflect weak efficiency.
- P/B ratio (~6.9) indicates expensive valuation.
- PEG ratio of 4.04 suggests stretched valuation relative to growth.
- Dividend yield of 0.13% offers negligible income.
Company Negative News
- Decline in FII holdings (-1.67%) signals reduced foreign investor confidence.
- MACD at -4.28 indicates bearish technical momentum.
Company Positive News
- Increase in DII holdings (+1.76%) reflects strong domestic institutional support.
- Quarterly PAT improved from ₹299 Cr. to ₹390 Cr.
- Strong demand outlook in protection and annuity products.
Industry
- Life insurance industry benefits from rising financial awareness and regulatory push for protection products.
- Industry P/E at 80.8 suggests sector trades at premium valuations.
- Competition from HDFC Life, SBI Life, and Max Life keeps pricing pressure high.
Conclusion
⚖️ ICICIPRULI is a stable life insurance company with strong brand presence and growth potential in protection and annuity segments. However, profitability ratios remain weak and valuations are stretched. Long-term investors can hold cautiously, while new investors should look for entry around ₹600–₹620 to optimize returns.
Would you like me to also prepare a peer comparison HTML snippet against HDFC Life and SBI Life to highlight relative strengths and weaknesses in the life insurance sector?